Rs. 126
Rs. 140
 10% off

Sri Sri Tattva Kabasura Kudineer 500mg Tablet

(60 tablets in bottle)
Sri Sri Tattva Kabasura Kudineer 500mg Tablet
Product Details
Sri Sri Tattva Kabasura Kudineer Tablet is a traditional formulation used by Siddha practitioners for effectively managing common respiratory ailments such as the flu and cold. This herbal formulation helps in relieving symptoms associated with respiratory health including severe phlegm, dry and wet cough and fever.

Key Ingredients:
  • Multi herbs

Indications:
This is indicated for enhancing your immunity and has anti-viral properties.

Potency: 500mg

Net Quantity: 60 Tabs

Product Form: Tablets

Key Benefits:
  • Sri Sri Tattva Kabasura Kudineer Tablet possesses strong anti-inflammatory, analgesic, anti-viral, anti-bacterial, anti-fungal, antioxidant, hepato-protective, antipyretic, anti-asthmatic and immunomodulatory properties
  • It is helpful in both prevention and deals with viral infections
  • It has an efficient inhibitory effect against viral replication

Dosage:
  • As advised by your healthcare practitioner

Safety Information:
  • Read the label carefully before use
  • Store in a cool and dry place, away from sunlight
  • Keep out of reach of children

Frequently Asked Question:
Q: How often should I take Sri Sri Tattva Kabasura Kudineer Tablet for respiratory issues?
A: The recommended dosage is typically twice a day, but it's advisable to consult with a healthcare professional for personalized guidance based on your specific condition.

Q: Can I take Kabasura Kudineer Tablet as a preventive measure against respiratory infections?
A: While it is traditionally used to manage respiratory ailments, it's essential to consult with a healthcare provider for advice on using it preventively, as individual health conditions vary.

Q: Are there any known side effects of using this herbal tablet for respiratory health?
A: Generally well-tolerated, but it's wise to inform your healthcare provider of any existing medical conditions or medications to ensure compatibility and address any potential concerns.

Content on this page was last updated on 28 February, 2024, by Dr. Varun Gupta (MD Pharmacology)